Shares slid 6.4% to $37.34 Friday as Oklo filed for a fresh at-the-market equity program — a mechanism that lets the company sell new shares gradually at prevailing prices — potentially flooding the market with up to $1 billion more in stock. The nuclear technology company's shares fell 3.5% Friday morning following the announcement. Major indexes were up on the day, confirming this is company-specific pain.

  • The Company Already Sold $1 Billion of Stock — and Wants to Do It Again

The new agreement replaces a prior equity distribution agreement dated May 13, 2026, which Oklo terminated the day before. Under that previous agreement, the company sold 17,971,448 shares for gross proceeds of approximately $1 billion.

The company is essentially rolling into a fresh $1 billion program having exhausted the previous one. For existing shareholders, each new batch of shares shrinks their slice of the pie — and shares outstanding have more than doubled in the last few years.

  • $3 Billion in Cash, Near-Zero Revenue, and Years to Wait

As of June 30, 2026, Oklo's cash, cash equivalents, and marketable debt securities were $3,006.3 million. So why raise more? Because the burn rate is accelerating: for the six months ended June 30, 2026, the company had a net loss of $81.6 million and loss from operations of $124.2 million.

Management expects 2026 cash used in operations of $120–$150 million and capital expenditures of $400–$500 million. At that pace, even a $3 billion war chest could be materially drained before power revenue arrives.

  • First Commercial Power Revenue Won't Come Before 2028

Oklo's latest quarterly filing described "an ambitious target of deploying our first powerhouse in 2028."

Management said the first revenue from its isotope business is more likely to come in the first part of 2027. The stock traded at roughly $37 with revenue forecast at just $805,600 for 2026 — meaning investors are pricing in a future that is, at minimum, two years away.

  • Wall Street Targets Remain Sky-High, but Dilution Is Forcing Downgrades

The consensus price target sits at $91.21 , more than double today's price. Yet at least one analyst has already cut their target, revising from $99 to $88 "due to dilution." The question is straightforward: Oklo has proven it can raise capital. It has yet to prove it can sell electricity. Until it does, every new share sold is a bet that the reactor timeline holds — and history shows nuclear projects rarely stay on schedule.